Advertisement
Research Article| Volume 81, ISSUE 1, P105-115, January 1973

Cerebrospinal fluid folate, and vitamin B12 in anticonvulsant-induced megaloblastosis

  • Eugene P. Frenkel
    Correspondence
    Reprint requests: Dr. Eugene P. Frenkel. Department of Internal Medicine, The University of Texas Southwestern Medical School, 5323 Harry Hines Blvd., Dallas, Texas 75235.
    Affiliations
    From the Department of Internal Medicine, The University of Texas Southwestern Medical School, Dallas, Texas U.S.A.

    From the Department of Nuclear Medicine, Veterans Administration Hospital, Dallas, Texas U.S.A.
    Search for articles by this author
  • Mary Sue McCall
    Affiliations
    From the Department of Internal Medicine, The University of Texas Southwestern Medical School, Dallas, Texas U.S.A.

    From the Department of Nuclear Medicine, Veterans Administration Hospital, Dallas, Texas U.S.A.
    Search for articles by this author
  • Richard G. Sheehan
    Affiliations
    From the Department of Internal Medicine, The University of Texas Southwestern Medical School, Dallas, Texas U.S.A.

    From the Department of Nuclear Medicine, Veterans Administration Hospital, Dallas, Texas U.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Anticonvulsant therapy commonly leads to the development of subnormal serum folate levels, and in some individuals to a true megaloblastic anemia. In addition, the folate depletion has been suggested as a basis for a variety of neurologic and psychiatric defects in such patients. Since neuropsychiatric changes are not seen in most circumstances of folate deprivation by other pathophysiologic mechanisms, a study of cerebrospinal fluid B12 and folate was performed in patients treated with anticonvulsants. Patients on long-term anticonvulsant therapy with no hematologic abnormality were found to have a lower mean cerebrospinal fluid (CSF) B12 level (9.7 pg. per milliliter) than normal subjects (mean: 17.8 pg. per milliliter). Nine patients with anticonvulsant-associated megaloblastosis had the expected low serum and CSF folate levels but in addition had mean CSF B12 levels of 3.7 pg. per milliliter. These CSF B12 levels were similar to those seen in classical pernicious anemia (mean of 1.2 pg. per milliliter). However, the anticonvulsant-associated megaloblastosis patients had a dichotomy between these CSF B12 values and their serum B12 levels, since all had normal or high serum B12 levels. Therapy with vitamin B12 resulted in a reticulocyte response and partial repair of the anemia and improvement in mentation with no increase in seizure rate. These studies suggest that the neuropsychiatric syndromes ascribed to the folate deprivation during anticonvulsant therapy may in fact be secondary to B12 depletion in the central nervous system (CNS) rather than a true folate deficiency.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mannheimer R
        • Pakesch F
        • Reimer EF
        • et al.
        Die Hematologischen Komplikationen der Epilepsie behandlung mit Hydantoinkorpern.
        Med Klin. 1952; 47: 1397
        • Badenoch J
        The use of labelled vitamin B12 and gastric biopsy in the investigation of anemia.
        in: Ed. 4. Proc Roy Soc Med. 47. 1954: 426-427
        • Hawkins CF
        • Meynell MJ
        Macrocytosis and macrocytic anemia caused by anticonvulsant drugs.
        Q J Med. 1958; 27: 45-63
        • Stokes JB
        • Fortune C
        Megaloblastic anaemia associated with anticonvulsant therapy.
        Austral Ann Med. 1958; 7: 118
        • Ungar B
        • Cowling DC
        Megaloblastic anaemia associated with anticonvulsant drug therapy.
        Med J Austral. 1960; 2: 461-462
        • Flexner JM
        • Hartmann RC
        Megaloblastic anemia associated with anticonvulsant drugs.
        Am J Med. 1960; 28: 386-396
        • Hawkins CF
        • Meynell MJ
        Megaloblastic anaemia due to phenytoin sodium.
        Lancet. 1954; 2: 737-738
        • Klipstein FA
        Subnormal serum folate and macrocytosis associated with anticonvulsant drug therapy.
        Blood. 1964; 23: 68-86
        • Malpas JS
        • Spray GH
        • Witts LJ
        Serum folic-acid and vitamin B12 levels in anti-convulsant therapy.
        Br Med J. 1966; 1: 955-957
        • Reynolds EH
        • Milner G
        • Matthews DM
        • et al.
        Anticonvulsant therapy, megaloblastic hematopoiesis, and folic acid metabolism.
        Q J Med. 1966; 35: 521-537
        • Ibbotson RN
        • Dilena BA
        • Horwood JM
        Studies on deficiency and absorption of folates in patients on anticonvulsant drugs.
        Austral Ann Med. 1967; 16: 144-150
        • Jensen ON
        • Olesen OV
        Folic acid and anticonvulsant drugs.
        Arch Neurol. 1969; 21: 208-214
        • Reynolds EH
        • Chanarin I
        • Matthews DM
        Neuropsychiatric aspects of anticonvulsant megaloblastic anaemia.
        Lancet. 1968; 1: 394-401
        • Reynolds EH
        • Chanarin I
        • Milner G
        • et al.
        Anticonvulsant therapy, folic acid, and vitamin B12 metabolism and mental symptoms.
        Epilepsia. 1966; 7: 261-270
        • Reynolds EH
        Schizophrenic-like psychoses of epilepsy and disturbances of folate and vitamin B12 metabolism induced by anticonvulsant drugs.
        Br J Psychiat. 1967; 113: 911-919
        • Reynolds EH
        • Preece J
        • Chanarin I
        Folic acid and anticonvulsants.
        Lancet. 1969; 1: 1264-1265
        • Strachan RW
        • Henderson JG
        Dementia and folate deficiency.
        Q J Med. 1967; 36: 189-204
        • Kane Jr, FJ
        • Lipton M
        Folic acid and mental illness.
        South Med J. 1970; 63: 603-607
        • Herbert V
        The megaloblastic anemias.
        in: Grune and Stratton, New York1959: 77
        • Cartwright GE
        Diagnostic laboratory hematology.
        in: Ed. 4. Grune and Stratton, New York1968: 13-87
        • Frenkel EP
        • Keller S
        • McCall MS
        Radioisotopic assay of serum vitamin B12 with the use of DEAE cellulose.
        J Lab Clin Med. 1966; 68: 510-522
        • Frenkel EP
        • McCall MS
        • White JD
        Recognition and resolution of errors in the radioisotopic assay of serum vitamin B12.
        Am J Clin Pathol. 1970; 53: 891-903
        • Frenkel EP
        • McCall MS
        • White JD
        An isotopic measurement of vitamin B12 in cerebrospinal fluid.
        Am J Clin Pathol. 1971; 55: 58-64
        • Herbert V
        Aseptic addition method for Lactobacillus casei assay of folate activity in human serum.
        J Clin Pathol. 1966; 19: 12-16
        • Spray GH
        Estimation of red cell folate activity.
        J Clin Pathol. 1969; 22: 212-216
        • Kutt H
        • Winters W
        • Scherman R
        • et al.
        Diphenylhydantoin and phenobarbital toxicity.
        Arch Neurol. 1964; 11: 649-656
        • Johns DG
        • Sperti S
        • Burgen ASV
        The metabolism of tritiated folic acid in man.
        J Clin Invest. 1961; 40: 1684-1695
        • Druskin MS
        • Wallen MH
        • Bonagura L
        Anticonvulsant-associated megaloblastic anemia.
        N Engl J Med. 1962; 267: 483-485
        • Hoffbrand AV
        • Necheles TF
        Mechanism of folate deficiency in patients receiving phenytoin.
        Lancet. 1968; 2: 528-530
        • Rosenberg IH
        • Godwin HA
        • Streiff RR
        • et al.
        Impairment of intestinal deconjugation of dietary folate.
        Lancet. 1968; 2: 530-532
        • Gerson CD
        • Hepner GW
        • Brown N
        • et al.
        Inhibition by diphenylhydantoin (Dilantin) of folic acid absorption in man.
        J Clin Invest. 1970; 49: 33a
        • Girdwood RH
        • Lenman JAR
        Megaloblastic anaemia occurring during primidone therapy.
        Br Med J. 1956; 1: 146-147
        • Anand MP
        Iatrogenic megaloblastic anaemia with neurological complications.
        Scot Med J. 1964; 9: 388-390
        • Hansen HA
        • Nordqvist P
        • Sourander P
        Megaloblastic anemia and neurologic disturbances combined with folic acid deficiency.
        Acta Med Scand. 1964; 176: 243-251
        • Luhby AL
        • Eagle FJ
        • Roth E
        • et al.
        Relapsing megaloblastic anemia in an infant due to a specific defect in gastrointestinal absorption of folic acid.
        Am J Dis Child. 1961; 102: 482-483
        • Lanzkowsky P
        • Erlandson ME
        • Bezan AI
        Isolated defect of folic acid absorption associated with mental retardation and cerebral calcification.
        Blood. 1969; 34: 452-465
        • Lanzkowsky P
        Congenital malabsorption of folate.
        Am J Med. 1970; 48: 580-583
        • Arakawa T
        • Fujii M
        • Ohara K
        • et al.
        Mental retardation with hyperfolic acidemia not associated with formiminoglutamic-aciduria; cyclohydrolase deficiency syndrome.
        Tohoku J Exp Med. 1966; 88: 341
        • Arakawa T
        • Narisawa K
        • Tanno K
        • et al.
        Megaloblastic anemia and mental retardation associated with hyperfolic-acidemia: Probably due to N5 methyltetrahydrofolate transferase deficiency.
        Tohoku J Exp Med. 1967; 93: 1-22
        • Arakawa T
        Congenital defects in folate utilization.
        Am J Med. 1970; 48: 594-598
        • Holmes JM
        Cerebral manifestations of vitamin-B12 deficiency.
        Br Med J. 1956; 2: 1394-1398
        • Herbert V
        Experimental nutritional folate deficiency in man.
        Trans Assoc Amer Phys. 1962; 75: 307-320
        • Woodard JC
        • Newberne PM
        Relation of vitamin B12 and one-carbon metabolism to hydrocephalus in the rat.
        J Nutr. 1966; 88: 375-381
        • Haltia M
        The effect of folate deficiency on neuronal RNA content.
        Br J Exp Pathol. 1970; 51: 191-195
        • Grant HC
        • Hoffbrand AV
        • Wells DG
        Folate deficiency and neurological disease.
        Lancet. 1965; 2: 763-767
        • Reynolds EH
        Effects of folic acid on the mental state and fit frequency of drug-treated epileptic patients.
        Lancet. 1967; 1: 1086-1088
        • Gibberd FB
        Epilepsy.
        Br Med J. 1969; 4: 281-284
        • Grant RHE
        • Stores OPR
        Folic acid in folate-deficient patients with epilepsy.
        Br Med J. 1970; 2: 644-648
        • Worm-Petersen J
        Vitamin B12 in the serum and cerebrospinal fluid in neurological diseases.
        Acta Neurol Scand. 1962; 38: 241-255
        • Schrumpf E
        • Bjelke E
        Vitamin B12 in the serum and cerebrospinal fluid.
        Acta Neurol Scand. 1970; 46: 243-248
        • Bauer H
        • Heinrich HC
        Vitamin B12 metabolism in neurological disease.
        in: Folch-Pi J Chemical pathways of the nervous system. Pergamon Press, Oxford1961: 120-125
        • Dohrmann GJ
        The choroid plexus: A historical review.
        Brain Res. 1970; 18: 197-218
        • Herbert V
        • Zalusky R
        Selective concentration of folic acid activity in cerebrospinal fluid.
        in: Fed Proc. 20. 1961: 453 (Abst.)
        • Herbert V
        Studies of folate deficiency in man.
        in: Proc Roy Soc Med. 57. 1964: 377-384
        • Spaan F
        No effect of folic acid supplement on CSF folate and serum vitamin B12 in patients on anticonvulsants.
        Epilepsia. 1970; 11: 403-411
        • Meyer LM
        • Bertcher RW
        • Mulzac C
        Co60 Vit. B12 binding capacity of normal human cerebrospinal fluid.
        in: Proc Soc Exp Biol Med. 100. 1959: 607-608
        • Clausen J
        • Munknev T
        Calcium and vitamin B12 binding to proteins in human serum and cerebrospinal fluid.
        Acta Pathol Microbiol Scand. 1962; 54: 129
        • Alperin JB
        Cerebrospinal fluid folate and the blood brain barrier.
        Clin Res. 1970; 18 (Abst.): 40
        • Lehtovaara R
        • Weckman N
        Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of patients with various neurological disorders.
        Neurol Klin. 1969; 85: 49-59
        • Horwitz SJ
        • Klipstein FA
        • Lovelace RE
        Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy.
        Lancet. 1968; 1: 563-565